UPLOAD: UPLOAD Post author:andrewkaretas Post published:March 29, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingUPLOAD: UPLOAD
CORRESP: CORRESP Post author:andrewkaretas Post published:March 29, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingCORRESP: CORRESP
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:March 18, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
S-8: Securities offered to employees pursuant to employee benefit plans Post author:andrewkaretas Post published:March 14, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingS-8: Securities offered to employees pursuant to employee benefit plans
S-3: Simplified registration form Post author:andrewkaretas Post published:March 14, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingS-3: Simplified registration form
10-K: Annual report which provides a comprehensive overview of the company for the past year Post author:andrewkaretas Post published:March 14, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading10-K: Annual report which provides a comprehensive overview of the company for the past year
POSASR: POSASR Post author:andrewkaretas Post published:March 14, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingPOSASR: POSASR
144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing Post author:andrewkaretas Post published:March 14, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading144: Filed by “insiders” prior intended sale of restricted stock. Non-EDGAR filing
8-K: Report of unscheduled material events or corporate event Post author:andrewkaretas Post published:March 14, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading8-K: Report of unscheduled material events or corporate event
10-K/A: Amendment to a previously filed 10-K Post author:andrewkaretas Post published:March 14, 2024 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading10-K/A: Amendment to a previously filed 10-K